TOPICAL CARBONIC-ANHYDRASE INHIBITORS IN THE TREATMENT OF GLAUCOMA

Authors
BAYER A FERRARI F MAREN TH ERB C
Citation
A. Bayer et al., TOPICAL CARBONIC-ANHYDRASE INHIBITORS IN THE TREATMENT OF GLAUCOMA, Journal francais d'ophtalmologie, 19(5), 1996, pp. 357-362
Citations number
30
Categorie Soggetti
Ophthalmology
Journal title
Journal francais d'ophtalmologie → ACNP
ISSN journal
01815512
Volume
19
Issue
5
Year of publication
1996
Pages
357 - 362
Database
ISI
SICI code
0181-5512(1996)19:5<357:TCIITT>2.0.ZU;2-9
Abstract
Systemically administered carbonic anhydrase inhibitors have been in c linical use since the 1950's. Their use and side effects have been rev iewed extensively. Our review summarizes the development of topically administered carbonic anhydrase inhibitors in patients with glaucoma. Moreover, it documents clinical trials leading to the present choice o f dorzolamide (MK-507), which is now being reviewed for worldwide appr oval for marketing by 1995.